InMode (INMD) Return on Capital Employed (2019 - 2026)
InMode (INMD) posted quarterly Return on Capital Employed of 11.72% for Q1 2026, down 465.0% year-on-year from 3.21% in Q1 2025, and down 6.72% on a QoQ basis from 12.56% in Q4 2025.
InMode (INMD) Return on Capital Employed (2019 - 2026) Analysis & Trends
InMode (INMD) has reported Return on Capital Employed for 8 consecutive years, with 11.72% the latest figure, recorded in Q1 2026.
- Quarterly Return on Capital Employed fell 465.0% year-over-year to 11.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.72% (down 465.0% YoY) and the FY2025 annual result came in at 12.11%, down 281.0% from the prior year.
- Return on Capital Employed declined to 11.72% in Q1 2026 per INMD's latest filing, from 12.56% in the prior quarter.
- Over the last five years, Return on Capital Employed for INMD reached as high as 42.07% in Q2 2022 and fell as low as 11.72% in Q1 2026.
- A 5-year average of 25.02% and a median of 21.26% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed soared 822 bps — and 2024, when it sank 1578 bps.
- Year by year, Return on Capital Employed stood at 37.35% in 2022, then slumped by 31 bps to 25.6% in 2023, then slumped by 40 bps to 15.31% in 2024, then declined by 18 bps to 12.56% in 2025, then declined by 7 bps to 11.72% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 11.72%, 12.56%, and 13.36% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 11.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.72% |
| Dec 31, 2025 | 12.56% |
| Sep 30, 2025 | 13.36% |
| Jun 30, 2025 | 17.91% |
| Mar 31, 2025 | 16.36% |
| Dec 31, 2024 | 15.31% |
| Sep 30, 2024 | 17.74% |
| Jun 30, 2024 | 17.23% |
| Mar 31, 2024 | 21.26% |
| Dec 31, 2023 | 25.60% |
| Sep 30, 2023 | 29.12% |
| Jun 30, 2023 | 33.01% |
| Mar 31, 2023 | 34.13% |
| Dec 31, 2022 | 37.35% |
| Sep 30, 2022 | 38.95% |
| Jun 30, 2022 | 42.07% |
| Mar 31, 2022 | 41.67% |
| Dec 31, 2021 | 40.72% |
| Sep 30, 2021 | 41.16% |
| Jun 30, 2021 | 39.95% |